Lista de obras - Gene G Olinger - Dominio Público Uruguay

A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus.

artículo científico publicado en 2010

Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses

artículo científico publicado en 2006

Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development

artículo científico publicado en 2013

Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses

artículo científico publicado en 2015

Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis

artículo científico publicado en 2014

Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1.

artículo científico publicado en 1999

Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression

artículo científico publicado en 1999

CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells

artículo científico publicado en 2000

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

artículo científico publicado en 2011

Cellular factors influence the binding of HIV type 1 to cells

artículo científico publicado en 2002

Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity

artículo científico publicado en 2013

Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.

artículo científico publicado en 2015

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

artículo científico publicado en 2012

Development of a model for marburgvirus based on severe-combined immunodeficiency mice

artículo científico publicado en 2007

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model

scientific article published on 27 August 2009

Donor variability in HIV binding to peripheral blood mononuclear cells.

artículo científico publicado en 2008

Ebola virus exploits a monocyte differentiation program to promote its entry

artículo científico publicado en 2013

Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent

artículo científico publicado en 2007

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge

artículo científico publicado en 2007

Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail

artículo científico publicado en 2015

Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant

artículo científico publicado en 2011

Evaluation of candidate vaccine approaches for MERS-CoV.

artículo científico publicado en 2015

Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus

artículo científico publicado en 2016

FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.

artículo científico publicado en 2013

FGI-104: a broad-spectrum small molecule inhibitor of viral infection

artículo científico publicado en 2009

Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names

artículo científico publicado en 2014

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents

artículo científico publicado en 2007

Filoviruses and the balance of innate, adaptive, and inflammatory responses

artículo científico publicado en 2006

Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo

artículo científico publicado en 2021

Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate

artículo científico publicado en 2018

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

artículo científico publicado en 2006

High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona

artículo científico publicado en 2017

High-dose mannose-binding lectin therapy for Ebola virus infection

artículo científico publicado en 2011

Human Antibodies to Major Histocompatibility Complex Alloantigens Mediate Lysis and Neutralization of HIV-1 Primary Isolate Virions in the Presence of Complement

article

Human antibodies to major histocompatibility complex alloantigens mediate lysis and neutralization of HIV-1 primary isolate virions in the presence of complement

scientific article published on 01 February 2001

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo

artículo científico publicado en 2016

In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus

artículo científico publicado en 2018

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection

artículo científico publicado en 2005

Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists

artículo científico publicado en 2015

Inhibition of heat-shock protein 90 reduces Ebola virus replication

artículo científico publicado en 2010

Interferon-β and Interferon-γ Are Weak Inhibitors of Ebola Virus in Cell-Based Assays

artículo científico publicado en 2017

Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever

artículo científico publicado en 2012

Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors

artículo científico publicado en 2013

Letter to the Editor

scholarly article published in December 1999

Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study

artículo científico publicado en 2015

MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses

scientific article published on 27 August 2020

Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization

artículo científico publicado en 2005

Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection

artículo científico publicado en 2013

Nonhuman Primate Models of Ebola Virus Disease

artículo científico publicado en 2017

Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques.

artículo científico publicado en 2012

Potential vaccines and post-exposure treatments for filovirus infections

artículo científico publicado en 2012

Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins

artículo científico publicado en 2005

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs

artículo científico publicado en 2015

Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever

artículo científico

Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells

artículo científico publicado en 2014

Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus.

artículo científico publicado en 2011

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

artículo científico publicado en 2014

Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry

artículo científico publicado en 2015

Standardization of the filovirus plaque assay for use in preclinical studies

artículo científico publicado en 2012

Structures of protective antibodies reveal sites of vulnerability on Ebola virus

artículo científico publicado en 2014

Targeting biodefense markets

artículo científico publicado en 2009

Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs

artículo científico publicado en 2018

The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection

artículo científico publicado en 2017

Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail

artículo científico publicado en 2013

Therapeutics Against Filovirus Infection

artículo científico publicado en 2017

Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay

artículo científico publicado en 2018

Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

artículo científico publicado en 2013

Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.

artículo científico publicado en 2017

Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA

artículo científico publicado en 2013

Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae

artículo científico publicado en 2013

Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae

artículo científico publicado en 2012

Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition.

artículo científico publicado en 2009

Lista de obras de Gene G Olinger

A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus.

Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses

Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development

Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses

Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis

Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1.

Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression

CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

Cellular factors influence the binding of HIV type 1 to cells

Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity

Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

Development of a model for marburgvirus based on severe-combined immunodeficiency mice

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model

Donor variability in HIV binding to peripheral blood mononuclear cells.

Ebola virus exploits a monocyte differentiation program to promote its entry

Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge

Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail

Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant

Evaluation of candidate vaccine approaches for MERS-CoV.

Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus

FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.

FGI-104: a broad-spectrum small molecule inhibitor of viral infection

Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents

Filoviruses and the balance of innate, adaptive, and inflammatory responses

Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo

Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona

High-dose mannose-binding lectin therapy for Ebola virus infection

Human Antibodies to Major Histocompatibility Complex Alloantigens Mediate Lysis and Neutralization of HIV-1 Primary Isolate Virions in the Presence of Complement

Human antibodies to major histocompatibility complex alloantigens mediate lysis and neutralization of HIV-1 primary isolate virions in the presence of complement

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo

In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection

Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists

Inhibition of heat-shock protein 90 reduces Ebola virus replication

Interferon-β and Interferon-γ Are Weak Inhibitors of Ebola Virus in Cell-Based Assays

Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever

Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors

Letter to the Editor

Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study

MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses

Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization

Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection

Nonhuman Primate Models of Ebola Virus Disease

Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques.

Potential vaccines and post-exposure treatments for filovirus infections

Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs

Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever

Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells

Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus.

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry

Standardization of the filovirus plaque assay for use in preclinical studies

Structures of protective antibodies reveal sites of vulnerability on Ebola virus

Targeting biodefense markets

Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs

The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection

Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail

Therapeutics Against Filovirus Infection

Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay

Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.

Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA

Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae

Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae

Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition.